Marc Beer’s Renovia Is Successful In Accumulating Funds For Women-Focused Startup

When it comes related to Biotechnology, Pharmaceuticals, and medically related startups, Marc Beer is not a stranger in developing meaningful products. He is the founder of Renovia, which focuses on finding and developing a cure for pelvic floor disorders that are plaguing women all around the world. Having the knowledge that he acquired in his earlier endeavors in ViaCell, Renovia developed a product called Leva, which is expected to give a revolutionary treatment for patients who have pelvic floor disorders.

 

Leva, which is under Renovia’s wing, is developed to help in diagnosing and treating people will Pelvic Floor Disorders, a condition which is known for being underdiagnosed and undertreated. Anyone can have this condition without knowing it. The Pelvic Floor is the part of the body that contains and support ligaments. tissues and the urinary tract. When things are not going smoothly in here, chances are the patient will develop urinary ailments such as the Urinary Incontinence. Urinary Incontinence is the uncontrolled leakage of urine which affects over 250 million women globally. This also has a lot of undiagnosed cases, just like other Pelvic Floor disorders and is expected to have a higher number because of this.

 

To cure urinary incontinence and other Pelvic Floor Disorders, Leva is being developed to aid in diagnosis and rehabilitation which is aided by modern technological advances such as Bluetooth. The good thing about this treatment and diagnosis is that surgery is not needed to treat the condition reduces the risk of other complications. Leva is among the four products that are being developed by Renovia in order to provide therapy and diagnosis for other diseases.

 

Marc Beer’s endeavors paid off because he and Renovia managed to raise a fund amounting to $32 million via a series B round funding which is made possible by the healthcare-focused investor The Longwood Fund. Another funding of $10 million is made possible through a venture debt. In total, there are $42 million fundings for the development of the four products.

 

In a press conference, Marc Beer thanked the investors who believe in the vision of his company and sent support for the Leva project. Now that the funding is secured, the other three products are planned to be developed. He also promised to make these revolutionary products useful in making techs that will uncover more about the Pelvic Floor Disorders and possibly, other cases in the medical world.

 

Marc Beer is one of the co-founders of Renovia, a firm which drives technology-driven products that improves diagnosis and treatments. He was also the founder of ViaCell, a firm that specializes in the preservation, collection, and development of stem cells from umbilical cord. The firm was acquired by PerkinElmer on 2007. Learn more: https://www.linkedin.com/in/marcbeer

 

Leave a Reply

Your email address will not be published. Required fields are marked *